par Biganzoli, Laura ;Cufer, T;Bruning, Peter;Coleman, R;Duchateau, L;Rapoport, Benjamin;Nooij, Marianne;Delhaye, François ;Miles, David J C;Sulkes, Aaron;Hamilton, Andrew;Piccart-Gebhart, Martine
Référence Cancer, 97, 1, page (40-45)
Publication Publié, 2003-01
Référence Cancer, 97, 1, page (40-45)
Publication Publié, 2003-01
Article révisé par les pairs
Titre: |
|
Auteur: | Biganzoli, Laura; Cufer, T; Bruning, Peter; Coleman, R; Duchateau, L; Rapoport, Benjamin; Nooij, Marianne; Delhaye, François; Miles, David J C; Sulkes, Aaron; Hamilton, Andrew; Piccart-Gebhart, Martine |
Informations sur la publication: | Cancer, 97, 1, page (40-45) |
Statut de publication: | Publié, 2003-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Cardiac toxicity |
Doxorubicin | |
Multicenter trials | |
Paclitaxel | |
MeSH keywords: | Adenocarcinoma -- drug therapy |
Adenocarcinoma -- secondary | |
Adult | |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- pathology | |
Cyclophosphamide -- administration & dosage | |
Disease Progression | |
Disease-Free Survival | |
Doxorubicin -- administration & dosage | |
Female | |
Follow-Up Studies | |
Heart -- drug effects | |
Humans | |
Middle Aged | |
Paclitaxel -- administration & dosage | |
Risk Factors | |
Safety | |
Survival Rate | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Comparative Study | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0008-543X |
info:doi/10.1002/cncr.10914 | |
info:scp/0037216170 | |
info:pmid/12491503 |